Hospital Universitario Ramon y Cajal

Madrid, Other 28034

0 studies enrolling now · 2 studies all time

What they study most

Fallopian Tube Cancer, HER2 Positive Breast Cancer, Ovarian Cancer, Peritoneal Cancer

Studies at this site

• A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer — Running, not enrolling
• A Study of Weekly Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With Safety Run-in (innovaTV 208) — Completed